AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine
In last year's update, AbbVie raised the combined 2027 net sales guidance for Skyrizi and Rinvoq by $6 billion to $27 billion ...
FiercePharma14d
JPM25, Day 3: AbbVie's 'clear runway to growth' allows it to focus on early-stage acquisitions
Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference ... Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several ...
pharmaphorum18d
AZ prepares for showdown with AbbVie/J&J as Calquence shines in CLL
AZ is also developing Calquence for CLL and other blood cancers, where it could compete with Johnson & Johnson/AbbVie’s Imbruvica (ibrutinib) and the company says it expects it to be an ...
GitHub19d
This is the official QuickFIX/J project repository.
QuickFIX/J is a full featured messaging engine for the FIX protocol (FIX versions 4.0 - 5.0SP2/FIXT1.1 and FIXLatest). It is a 100% Java open source implementation of the popular C++ QuickFIX engine.
Nasdaq20d
AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill., Jan. 9, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate ...
Yahoo Finance20d
AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill., Jan. 9, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate in a ...